You can buy or sell ELOX and other stocks, options, ETFs, and crypto commission-free!
Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Read More It operates through the United States and Israel geographical segments. Its product includes ELX-02, a small molecule drug designed to restore production of full-length functional proteins which treats cystic fibrosis and cystinosis. The company was founded on December 19, 2017 and is headquartered in Waltham, MA.
52 Week High
52 Week Low
The Motley FoolMar 8
Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2018 Earnings Conference Call Transcript
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Q4 2018 Earnings Conference Call , 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good morning, everyone, and welcome to Eloxx Pharmaceuticals Fourth Quarter and Full-Year 2018 Earnings Webcast and Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Barbara Ryan, Eloxx's Investor Relations Officer. Please begin. Barbara Ryan -- Investor Relations O...
-$0.40 per share